WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Can a single, cheap pill combat cardiovascular disease?

Details
Research
19 May 2010
Volunteers are being recruited in Ireland, the Netherlands and the UK to participate in a two-year trial of a single 'polypill' designed to prevent heart attack and stroke. The trials are financed in part by the UMPIRE (Use of a multidrug pill in reducing cardiovascular events) project, which has received EUR 3 million under the Health Theme of the Seventh Framework Programme (FP7).
Read more ...

How Unbranded Websites Can Extend Brand Reach throughout the Patient Life Cycle?

Details
Research
11 May 2010
Manhattan ResearchConsumer reliance on condition-focused content during the disease research process, growing emphasis on customer care throughout the treatment continuum, and uncertainty around the DTC regulatory environment is prompting increased interest in unbranded online initiatives.
Read more ...

The IT @ Networking Awards 2010

Details
Research
30 April 2010
The goal of the IT @ Networking Awards 2010 (IT @ 2010), is to honour and promote outstanding healthcare IT solutions. The core aim of IT @ 2010 is to learn from the achievements of the very best IT installations on the globe.
Read more ...

Study Reveals Exciting Physician Growth in the Areas of Mobile, Social, and Online Access

Details
Research
27 April 2010
Manhattan ResearchPhysicians show continued adoption of mobile and social media for professional purposes, as well as increasing dependency on digital resources at the point of care, according to pharmaceutical and healthcare market research company Manhattan Research's latest Taking the PulseĀ® study of over 2,000 U.S. physicians.
Read more ...

EU-funded study investigates kidney regeneration potential

Details
Research
13 April 2010
A paper published in The Lancet journal, as part of a series on renal medicine, has questioned if kidney regeneration may be possible in human beings as it is in fish and other lower vertebrates.
Read more ...

Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry

Details
Research
09 April 2010
The economic recovery process has proved difficult for the pharmaceutical industry. Factors like patent expiry, dry pipeline, and strict approval guidelines, have slowed down the attractive drug discovery and industry growth. Coupled with an investment risk in new therapy or molecules, this creates a challenge for the industry to overcome.
Read more ...

Two Compounds Discovered that Pave the Way for New Class of AIDS Drug

Details
Research
26 March 2010
According to the World Health Organization, about 33 million people currently live with HIV infections. Several drugs used to treat AIDS inhibit this HIV protease target, but drug-resistant mutants that impede the effectiveness of these drugs keep appearing and getting worse.
Read more ...

More Pharma News ...

  1. Electronic Clinical Decision Support for Middle Eastern Hospitals
  2. Google Announces Public Data Explorer
  3. MitoTarget Launches New Online Resource for Physicians and Sufferers from Rare Illness ALS
  4. EU-funded researchers sequence human gut microbe genome
  5. Physicians Will Expand Range of Mobile Activities to Include Administrative and Patient Care Tasks
  6. Funds Boost Research into Causes, Interventions for Age-Related Cognitive Decline
  7. Powerful Universal Search Engine Makes Scientific Research Easy to Find
  • Start
  • Prev
  • 276
  • 277
  • 278
  • 279
  • 280
  • 281
  • 282
  • 283
  • 284
  • 285
  • Next
  • End
Tahmeena

Business & Industry

  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
  • Acquisition of Neogene Therapeutics completed
  • Bayer to accelerate drug discovery with Google Cloud's high-performance compute power
  • NextPoint Therapeutics announces $80 million Series B financing co-led by Leaps by Bayer and Sanofi Ventures to advance novel immuno-oncology programs

Research & Development

  • Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment
  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic
  • Modified CRISPR-based enzymes improve the prospect of inserting entire genes into the genome to overcome diverse disease-causing mutations

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Research
  4. Keys to making immunotherapy work against pancreatic cancer found in tumor microenvironment

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.